Revenues are Increasing though despite, revenue per script.
Shareholders know that the compounding reimbursement changes resulted in $2 million in less revenue for the year.
And Still Revenues Increased
2017 Net Revenues = $20.1 million
2018 Net Revenues = $21.3 million estimated ($19.435 million through 11 months)
Not including the rise seen in 340B Prescriptions Gross Revenue from
2017 = $2.75 million
2018 = $5.88 million estimated ($5.28 million through 11 months)
"To Give Anything Less Than Your Best, Is To Sacrifice the Gift." - Steve Prefontaine
Selling shares at $.019 prior to run to $.26 would have been my biggest failure. Glad it wasn't me!! ;-)